MedTrace Logo

Skin IaM: An Exploratory Clinical Trial to Evaluate Changes in Skin Appearance, Colour, and/or Texture Following the Induction of a Local Inflammatory Skin Response

NCT03192280 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2025-02-24

No results posted yet for this study

Summary

This trial will test the feasibility of various imaging devices to detect local skin inflammation prior to clinical manifestation.

Conditions

  • Skin Inflammation

Interventions

DRUG

Leukotriene B4

Leukotriene B4 (LTB4)

DEVICE

FLIR One

Thermal imaging attachment to iPhone

DEVICE

SCIO

Handheld near-IR molecular spectroscopy device

DEVICE

MS Band 2

Wearable "watch-like" device with multiple sensors

DEVICE

AGE reader

Portable bench top device for in-clinic near UV assessment

DEVICE

HSI prototype (PARC) hyper-spectral camera

Portable bench top device for in-clinic multispectral imaging

DEVICE

iPhone 7

Smart phone

Sponsors & Collaborators

  • LEO Pharma

    lead INDUSTRY

Principal Investigators

  • Paul Griffin, MD · Q-Pharm Pty Limited

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-06-19
Primary Completion
2017-07-06
Completion
2017-07-06

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03192280 on ClinicalTrials.gov